top of page
Resources > Articles
Regulatory Intelligence,
In Depth.
Articles, whitepapers, guides, and case studies for Life Sciences regulatory professionals navigating a faster, more complex regulatory world.
Management Review Under QMSR: Why “Top Management” Now Means the CEO
QMSR brings ISO 13485's management responsibility clauses into FDA regulation. What "top management" engagement in management review now requires, and how to show executive accountability that holds up at inspection.
Sep 224 min read
Separating CAPA Workflows Under QMSR: What Manufacturers Actually Need to Change
CAPA deficiencies remain one of FDA's most reliable predictors of enforcement. What separating corrective and preventive action workflows looks like under QMSR, and what manufacturers actually need to change in their quality systems.
Sep 224 min read
MDSAP in 2026: How the Single Audit Program Works After QMSR
The Medical Device Single Audit Program promises one audit that satisfies multiple regulators. How MDSAP works in 2026, what changed with QMSR and the program's new governance, and how quality teams can prepare for an audit designed to find more than a standard ISO 13485 certification would.
Sep 2210 min read
Risk Management Under QMSR: Why ISO 14971 Is Now the Center of FDA Inspections
How FDA's QMSR treats risk management through ISO 13485 and ISO 14971, the most common file weaknesses, and how to build a living risk management system.
Sep 229 min read
Design Controls Under QMSR: What Changes When 820.30 Becomes ISO 13485 Clause 7.3
A clause-by-clause comparison of QSR 820.30 and ISO 13485 clause 7.3 under FDA's QMSR, with terminology changes, inspection focus areas and a transition checklist.
Sep 228 min read
bottom of page